Program Schedule

155
Implementation of a national surveillance program for antimicrobial use, Colombia 2012-2013

Session: Poster Abstract Session: Antibiotic Stewardship
Thursday, October 9, 2014
Room: The Pennsylvania Convention Center: IDExpo Hall BC
Background: Bacterial resistance is considered a major public health problem, with greater impact on developing countries. However, in our country, few institutions of antimicrobial management programs Objectives: Establish a national surveillance of antimicrobial use for prescription habits and so it appropriate institutional policies set

Methods: 1. Through Management Colombian Association of infectious diseases public and private institutions in the country were invited to voluntarily form a surveillance network for rational use ofantimicrobials.
2. Antibiotic consumption was standardized using DDD x 100 day beds for consolidating information in each institution, according to the guidelines of the World Health Organization.
3. a website accessible to all institutions was developed , in order to educate, collect usage information on a monthly basis for antimicrobial , This tool allows real-time calculation of consumption rates and make institutional compared to national averages
.

Results: Data from 30 institutions that make up the network of surveillance of antimicrobial use for 24 months follow-up were included. Describes the DDD per 100 beds/day of major groups of antimicrobials in Figure 1 and 2. It also was possible to establish trends in prescription of each molecule or group of intra-and inter-institutionally AB monthly in the period.

Conclusion: The creation of a network of antimicrobials was successful and from this information considered the baseline and in conjunction with the analysis of resistance profiles, it is possible to make recommendations to improve or establish antimicrobial management programs

Carlos Arturo Alvarez Moreno, Physician infectious diseases, Clinical Colombia, bogota, Colombia, David Leonardo Mantilla Borda, hiv medical expert, infectoclinic, bogota, Colombia and Abacin Group

Disclosures:

C. A. Alvarez Moreno, None

D. L. Mantilla Borda, None

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, idweek.org. All Rights Reserved.

Follow IDWeek